期刊
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
卷 2022, 期 -, 页码 -出版社
HINDAWI LTD
DOI: 10.1155/2022/3115312
关键词
-
资金
- National Natural Science Foundation of China [81572393, 81602093, 81972888]
- Natural Science Foundation of Jiangsu Province [BK20160118]
- Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau [ZKX15020, ZKX17022]
- Research Fund for Hepatobiliary and Pancreatic Malignant Tumors, Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province [CXPJJH12000001-2020318]
- Fundamental Research Funds for the Central Universities [021414380215, 020414380080, 021414380329]
The study found that myricetin induces apoptosis in hepatocellular carcinoma cells by activating endoplasmic reticulum stress and upregulating protective autophagy. Inhibition of autophagy enhances the anti-cancer activity of myricetin.
Myricetin, a natural flavonoid, exhibits diverse biological activities, including antitumor effects. The present study aimed to investigate the effects of myricetin on hepatocellular carcinoma (HCC) cells and explore the underlying molecular mechanisms. Our results showed that myricetin significantly inhibited cell proliferation and induced apoptosis in HCC cells. The apoptosis induced by myricetin was associated with the activation of endoplasmic reticulum (ER) stress. In addition, autophagy was enhanced in response to ER stress. Inhibition of autophagy by RNA interference or chemical inhibitors resulted in increased apoptosis in myricetin-treated HCC cells. The in vivo experiment also showed that myricetin effectively reduced tumor growth in an HCC xenograft model and that combination treatment with an autophagy inhibitor significantly enhanced this effect. These results indicated that myricetin induced apoptosis in HCC cells through the activation of ER stress. Protective autophagy was also upregulated during this process. Simultaneous inhibition of autophagy enhanced the anti-HCC activity of myricetin. Myricetin might be a promising drug candidate for HCC therapy, and the combined use of myricetin with autophagy inhibitors could be an effective therapeutic strategy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据